Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists

Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists

US Patent 9174985 · Granted Nov 3, 2015

Estimated economic value: $22,668,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and compositions for inhibiting the activity of HIF2-alpha and their m2025
Pyrazolyl derivatives useful as anti-cancer agents2023
Formylated N-heterocyclic derivatives as FGFR4 inhibitors2020
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors2019
Benzothiazolone compound2019
Formylated N-heterocyclic derivatives as FGFR4 inhibitors2019
Pharmaceutical combinations2018
Benzothiazolone compound2018
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors2018
Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-me2017
Formulation comprising benzothiazolone compound2017
IP receptor agonist heterocyclic compounds2017